REGistry of Long-term AnTithrombotic TherApy-2

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 15, 2015

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Atrial Fibrillation
Interventions
DRUG

Anticoagulants

oral anticoagulants, dual or triple antithrombotic theraphy

Trial Locations (1)

121552

RECRUITING

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation, Moscow

All Listed Sponsors
lead

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

OTHER_GOV